AllQuantitative Report
logoArgusOctober 15, 2020

ARWR: Lowering target price to $54.00

Symbols
ARWR
Sector(s)
Healthcare
Rating
Premium
Current Price
$62.99
Price Target
$NaN
Earnings Estimate
Premium
Summary

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins.

Premium
Subscribe to Yahoo Finance Premium for full access
Read the latest independent research including analyst forecasts, ratings on the US economy, and more. Get individual company and overall sector level recommendations.
Try Premium FREE